Publications by authors named "Abner S"

Article Synopsis
  • Duchenne muscular dystrophy (DMD) leads to severe muscle degeneration and increased risk of heart problems; the review aimed to identify factors predicting cardiac disease in DMD patients.
  • The systematic review examined literature from 2000 to 2022, analyzing 33 studies involving over 9,200 DMD patients and assessing the strength of the evidence using the GRADE framework.
  • Key findings indicated that certain cardiac medications and DMD gene mutations are linked to better heart function, while glucocorticoids improve left ventricular performance, with varying evidence quality regarding their effectiveness.
View Article and Find Full Text PDF

The search for an efficient and stable catalyst for the electrochemical reduction of CO to value-added chemicals is especially critical for lowering the atmospheric CO concentration. In this study, self-supported cobalt/copper nanostructured catalysts were designed, where the influences of the elemental composition and acid-etching on their efficiency towards the CO reduction reaction were studied. The developed Co/Cu catalysts showed superb catalytic activity with a low onset potential at -0.

View Article and Find Full Text PDF

Objective: The objective of this study was to describe predictors of loss of ambulation in Duchenne muscular dystrophy (DMD).

Methods: This systematic review and meta-analysis included searches of MEDLINE ALL, Embase, and the Cochrane Database of Systematic Reviews from January 1, 2000, to December 31, 2022, for predictors of loss of ambulation in DMD. Search terms included "Duchenne muscular dystrophy" as a Medical Subject Heading or free text term, in combination with variations of the term "predictor".

View Article and Find Full Text PDF
Article Synopsis
  • The article discusses the NHSN's use of automation in public health surveillance through digital quality measures (dQMs) using an open-source tool called NHSNLink, and a pilot program (NHSNCoLab) with real-world data.
  • It focuses on leveraging FHIR APIs to enhance data collection and reporting related to significant and preventable patient harms like medication-related complications and infections.
  • The findings suggest that implementing FHIR dQMs can reduce reporting burdens while improving the accuracy, quality, and efficiency of data for public health and patient safety.
View Article and Find Full Text PDF

Background And Objectives: Bisphosphonates are routinely used to treat osteoporosis in patients with Duchenne muscular dystrophy (DMD), a rare, severely debilitating neuromuscular disease. We sought to synthesize and grade benefits and harms evidence of bisphosphonates in glucocorticoid-treated patients with DMD.

Methods: In this systematic review (PROSPERO identifier: CRD42020157606), we searched MEDLINE, CINAHL, Embase, PsycINFO, Web of Science, and CENTRAL for articles published from inception up to and including March 31, 2023, reporting results in any language from any study type.

View Article and Find Full Text PDF

Background: Spinal muscular atrophy (SMA) is a rare, severely debilitating neuromuscular disease characterized by a wide spectrum of progressive muscular atrophy and weakness.

Objectives: The objective of this pilot study was to estimate self-assessed health-related quality of life (HRQoL) of children with SMA.

Methods: Children with SMA were recruited via the German national TREAT-NMD SMA patient registry and asked to self-complete the following rating-scales: KIDSCREEN-27, KINDL, the PedsQL 3.

View Article and Find Full Text PDF

Background: Despite advances in the medical management of the disease, respiratory involvement remains a significant source of morbidity and mortality in children and adults with Duchenne muscular dystrophy (DMD).

Objective: The objective of this systematic literature review was to synthesize and grade published evidence of factors associated with respiratory health and function in DMD.

Methods: We searched MEDLINE, Embase, and the Cochrane Library for records of studies published from January 1, 2000 (to ensure relevance to current care practices), up until and including December 31, 2022, reporting evidence of prognostic indicators and predictors of disease progression in DMD.

View Article and Find Full Text PDF

Aim: Despite global recommendations for type 2 diabetes mellitus treatment to maintain optimal glycaemic targets, a significant proportion of people remain in suboptimal glycaemic control. Our objective was to investigate the impact of intensification delay after basal insulin (BI) initiation on long-term complications in people with suboptimal glycaemia.

Materials And Methods: We conducted a retrospective cohort study in individuals with type 2 diabetes mellitus initiated on BI.

View Article and Find Full Text PDF

Background And Aims: Currently, there is uncertainty as to whether blood pressure control in patients with type 2 diabetes should be treated to standard recommended levels or more intensively.

Methods: Medline, EMBASE, CENTRAL, and Clinicaltrials.gov were searched between January 1, 2000 and April 20th, 2023.

View Article and Find Full Text PDF

Background: Management and treatment of spinal muscular atrophy (SMA) has changed in recent years due to the introduction of novel transformative and potentially curative therapies resulting in the emergence of new disease phenotypes. Yet, little is known about the uptake and impact of these therapies in real-world clinical practice. The objective of this study was to describe current motor function, need of assistive devices, and therapeutic and supportive interventions provided by the healthcare system, as well as the socioeconomic situation of children and adults with different SMA phenotypes in Germany.

View Article and Find Full Text PDF

Objective: The objective of our study was to review, synthesize, and grade published evidence of caregiver burden of spinal muscular atrophy (SMA), a rare autosomal-recessive neuromuscular disease.

Methods: We searched Embase and PubMed for full-text articles published from inception up until 28 February, 2022, reporting results from studies of caregiver burden (i.e.

View Article and Find Full Text PDF

Herein, we report on the facile synthesis of nanocomposite consisting of TiO and Au nanoparticles (NPs) via a tailored galvanic replacement reaction (GRR). The electrocatalytic activity of the synthesized TiO/Au nanocomposites for CO reduction was investigated in an aqueous solution using various electrochemical methods. Our results demonstrated that the TiO/Au nanocomposites formed through the GRR process exhibited improved catalytic activities for CO reduction, while generating more hydrocarbon molecules than the typical formation of CO in contrast to polycrystalline Au.

View Article and Find Full Text PDF

Aims: To quantify ethnic differences in the risk of all-cause mortality and cardiovascular disease (CVD) events following a first CVD event in people with and without type 2 diabetes.

Methods: We identified 5,349,271 subjects with a first CVD between 1 January 2002 and 31 May 2020 in England; CVD included aortic aneurism, cerebrovascular accident, heart failure, myocardial infarction, peripheral vascular disease, and other cardiovascular diseases. We estimated adjusted hazard ratios (HRs) for type 2 diabetes and ethnicity of three outcomes: fatal and nonfatal second CVD event (different phenotype compared to the first) and all-cause mortality.

View Article and Find Full Text PDF

Background: Identifying features associated with atrial fibrillation (AF) documentation could inform screening. This study used published data to describe differences in documented and estimated AF prevalence in general practices, and explored predictors of variations in AF prevalence.

Methods: Cross-sectional study of 7318 general practices in England.

View Article and Find Full Text PDF

Objective: To assess trends in primary and specialist care consultation rates and average length of consultation by cardiovascular disease (CVD), type 2 diabetes mellitus (T2DM), or cardiometabolic multimorbidity exposure status.

Methods: Observational, retrospective cohort study used linked Clinical Practice Research Datalink primary care data from 01/01/2000 to 31/12/2018 to assess consultation rates in 141,328 adults with newly diagnosed T2DM, with or without CVD. Patients who entered the study with either a diagnosis of T2DM or CVD and later developed the second condition during the study are classified as the cardiometabolic multimorbidity group.

View Article and Find Full Text PDF

Aims: Diabetes can significantly impact quality of life and mental health. However, inconsistencies have been reported in the prevalence of depression in those with Type 1 and Type 2 diabetes, and those without. Systematic reviews also included studies without adequate control subjects.

View Article and Find Full Text PDF

Objective: To estimate and compare progression rates to type 2 diabetes mellitus (T2DM) in women with gestational diabetes mellitus (GDM) and healthy controls.

Design: Systematic review and meta-analysis.

Data Sources: Medline and Embase between January 2000 and December 2019, studies published in English and conducted on humans.

View Article and Find Full Text PDF

Objective: Describe common pathogens and antimicrobial resistance patterns for healthcare-associated infections (HAIs) that occurred during 2015-2017 and were reported to the Centers for Disease Control and Prevention's (CDC's) National Healthcare Safety Network (NHSN).

Methods: Data from central line-associated bloodstream infections (CLABSIs), catheter-associated urinary tract infections (CAUTIs), ventilator-associated events (VAEs), and surgical site infections (SSIs) were reported from acute-care hospitals, long-term acute-care hospitals, and inpatient rehabilitation facilities. This analysis included device-associated HAIs reported from adult location types, and SSIs among patients ≥18 years old.

View Article and Find Full Text PDF

Objective: To describe common pathogens and antimicrobial resistance patterns for healthcare-associated infections (HAIs) among pediatric patients that occurred in 2015-2017 and were reported to the Centers for Disease Control and Prevention's National Healthcare Safety Network (NHSN).

Methods: Antimicrobial resistance data were analyzed for pathogens implicated in central line-associated bloodstream infections (CLABSIs), catheter-associated urinary tract infections (CAUTIs), ventilator-associated pneumonias (VAPs), and surgical site infections (SSIs). This analysis was restricted to device-associated HAIs reported from pediatric patient care locations and SSIs among patients <18 years old.

View Article and Find Full Text PDF

Objective: To examine the association of comorbid occurrence of diabetes and depression with risk of cardiovascular endpoints including cardiovascular mortality, coronary heart disease and stroke.

Research Design And Methods: A systematic review and metaanalysis. We searched PUBMED/MEDLINE, Medscape, Cochrane Library, CINAHL, EMBASE and Scopus databases assessing cardiac events and mortality associated with depression in diabetes up until 1 December 2018.

View Article and Find Full Text PDF

Background: It is important to better understand the role that environmental risk factors play on the development of esophageal cancer in Howel-Evans families. Additionally, there is little published about appropriate esophageal cancer screening practices in families genetically confirmed to have this condition.

Methods: Surveys were distributed to 47 addresses of an American family with Howel-Evans syndrome, of which 29 responded and met inclusion criteria.

View Article and Find Full Text PDF

Angioinvasive (type E) lymphomatoid papulosis (LyP) is a recently described subtype of LyP presenting with eschar-like lesions that can be mistaken for aggressive forms of angiocentric cutaneous T-cell lymphoma. None of the cases of angioinvasive LyP described thus far have been associated with mycosis fungoides (MF). Herein, we describe a case of angioinvasive LyP type E coexisting with MF.

View Article and Find Full Text PDF

Background: A recent epidemiological study demonstrated a reduced risk of lung cancer mortality in breast cancer patients using antiestrogens. These and other data implicate a role for estrogens in lung cancer, particularly nonsmall cell lung cancer (NSCLC). Approximately 61% of human NSCLC tumors express nuclear estrogen receptor β (ERβ); however, the role of ERβ and estrogens in NSCLC is likely to be multifactorial.

View Article and Find Full Text PDF